MAG and neuropathy: This is the first study demonstrating that QoL, measured with SF36 questionnaire, was lower in patients with anti-MAG antibody neuropathy compared with the Italian general population [7], consistently with a previous study performed in French and English anti-MAG neuropathy population [8].